- Home
- IMRN vs SINT Comparison
IMRN vs SINT Comparison
Compare IMRN & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- SINT
- Stock Information
- Founded
- IMRN 1994
- SINT 1996
- Country
- IMRN Australia
- SINT United States
- Employees
- IMRN N/A
- SINT N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- SINT Medical/Dental Instruments
- Sector
- IMRN Health Care
- SINT Health Care
- Exchange
- IMRN Nasdaq
- SINT Nasdaq
- Market Cap
- IMRN 9.2M
- SINT 7.9M
- IPO Year
- IMRN N/A
- SINT 2014
- Fundamental
- Price
- IMRN $1.74
- SINT $3.20
- Analyst Decision
- IMRN Strong Buy
- SINT Strong Buy
- Analyst Count
- IMRN 1
- SINT 1
- Target Price
- IMRN $5.00
- SINT $28.00
- AVG Volume (30 Days)
- IMRN 24.7K
- SINT 54.9K
- Earning Date
- IMRN 07-07-2025
- SINT 08-12-2025
- Dividend Yield
- IMRN N/A
- SINT N/A
- EPS Growth
- IMRN N/A
- SINT N/A
- EPS
- IMRN N/A
- SINT N/A
- Revenue
- IMRN $4,048,286.00
- SINT $2,569,000.00
- Revenue This Year
- IMRN N/A
- SINT $3.26
- Revenue Next Year
- IMRN N/A
- SINT $21.87
- P/E Ratio
- IMRN N/A
- SINT N/A
- Revenue Growth
- IMRN 82.90
- SINT N/A
- 52 Week Low
- IMRN $1.50
- SINT $1.71
- 52 Week High
- IMRN $2.87
- SINT $8.60
- Technical
- Relative Strength Index (RSI)
- IMRN 58.70
- SINT 54.73
- Support Level
- IMRN $1.68
- SINT $3.05
- Resistance Level
- IMRN $1.94
- SINT $3.38
- Average True Range (ATR)
- IMRN 0.09
- SINT 0.23
- MACD
- IMRN 0.02
- SINT -0.00
- Stochastic Oscillator
- IMRN 76.92
- SINT 45.12
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.